KROS — Keros Therapeutics, Inc. stock price, charts and financials

QT40Keros Therapeutics, Inc.

Keros Therapeutics, Inc. (NASDAQ: KROS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.19
-0.17-1.50%
OverviewShort InterestFilings
KROSQT40Keros Therapeutics, Inc.·NASDAQ
11.19-1.50%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 16, 2026EFFECTNotice of effectiveness
Sep 11, 2026DEL AMDEL AM
Sep 10, 2026S-3Shelf registration statement
Sep 08, 20268-KCurrent report
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 13, 20263Initial statement of beneficial ownership
Aug 03, 20268-KCurrent report
Aug 03, 202610-QQuarterly report
Aug 03, 20268-KCurrent report
Jul 30, 20268-KCurrent report
Jul 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 22, 20268-KCurrent report
Jul 17, 2026SC 13GBeneficial ownership statement (passive)
Jul 17, 20264Statement of changes in beneficial ownership
Jul 06, 20263Initial statement of beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jun 25, 20268-KCurrent report
Jun 17, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
#1 / 25 of 371
Page
▼
/ 15